This document is scheduled to be published in the

Federal Register on 02/26/2013 and available online at

http://federalregister.gov/a/2013-04288, and on FDsys.gov

DEPARTMENT OF HEALTH AND HUMAN SERVICES 

Centers for Medicare & Medicaid Services 

[CMS-3283-N] 

Medicare Program; Meeting of the Medicare Evidence Development and Coverage 

Advisory Committee—May 1, 2013 

AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS. 

ACTION: Notice of meeting. 

SUMMARY: This notice announces that a public meeting of the Medicare Evidence 

Development & Coverage Advisory Committee (MEDCAC) ("Committee") will be held 

on Wednesday, May 1, 2013. The Committee generally provides advice and 

recommendations concerning the adequacy of scientific evidence needed to determine 

whether certain medical items and services can be covered under the Medicare statute. 

This meeting will focus on selected genetic tests for cancer diagnosis (for cancers of 

unknown primary site and for cervical cytology findings of uncertain clinical 

significance). This meeting is open to the public in accordance with the Federal 

Advisory Committee Act (5 U.S.C. App. 2, section 10(a)). 

DATES: Meeting Date: The public meeting will be held on Wednesday, May 1, 2013 

from 7:30 a.m. until 4:30 p.m., Eastern Daylight Time (EDT). 

Deadline for Submission of Written Comments: Written comments must be received at 

the address specified in the ADDRESSES section of this notice by 5 p.m., EDT, 

Monday, March 25, 2013. Once submitted, all comments are final. 

Deadlines for Speaker Registration and Presentation Materials: The deadline to register 

to be a speaker and to submit PowerPoint presentation materials and writings that will be 
 2 

used in support of an oral presentation is 5:00 p.m., EDT on Monday, April 1, 2013. 

Speakers may register by phone or via e-mail by contacting the person listed in the FOR 

FURTHER INFORMATION CONTACT section of this notice. Presentation materials 

must be received at the address specified in the ADDRESSES section of this notice. 

Deadline for All Other Attendees Registration: Individuals may register online at 

http://www.cms.gov/apps/events/upcomingevents.asp?strOrderBy=1&type=3 or by 

phone by contacting the person listed in the FOR FURTHER INFORMATION 

CONTACT section of this notice by 5 p.m. EDT, Wednesday, April 24, 2013. 

We will be broadcasting the meeting live via Webcast at http://www.cms.gov/live/. 

Deadline for Submitting a Request for Special Accommodations: Persons attending the 

meeting who are hearing or visually impaired, or have a condition that requires special 

assistance or accommodations, are asked to contact the Executive Secretary as specified 

in the FOR FURTHER INFORMATION CONTACT section of this notice no later 

than 5:00 p.m., EDT Friday, April 12, 2013. 

ADDRESSES: Meeting Location: The meeting will be held in the main auditorium of 

the Centers for Medicare & Medicaid Services, 7500 Security Boulevard, Baltimore, MD 

21244. 

Submission of Presentations and Comments: Presentation materials and written 

comments that will be presented at the meeting must be submitted via e-mail to 

MedCACpresentations@cms.hhs.gov or by regular mail to the contact listed in the 

FOR FURTHER INFORMATION CONTACT section of this notice by the date 

specified in the DATES section of this notice. 

FOR FURTHER INFORMATION CONTACT: Maria Ellis, Executive Secretary for 
 3 

MEDCAC, Centers for Medicare & Medicaid Services, Center for Clinical Standards and 

Quality, Coverage and Analysis Group, S3-02-01, 7500 Security Boulevard, Baltimore, 

MD 21244 or contact Ms. Ellis by phone (410-786-0309) or via e-mail at 

Maria.Ellis@cms.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

I. Background 

 MEDCAC, formerly known as the Medicare Coverage Advisory Committee 

(MCAC), provides advice and recommendations to CMS regarding clinical issues. 

(For more information on MCAC, see the December 14, 1998 Federal Register

(63 FR 68780). This notice announces the Wednesday, May 1, 2013, public meeting of 

the Committee. During this meeting, the Committee will discuss selected genetic tests 

for cancer diagnosis (for cancers of unknown primary site and for cervical cytology 

findings of uncertain clinical significance).

Background information about this topic, including panel materials, is available at 

http://www.cms.gov/medicare-coverage-database/indexes/medcac-meetingsindex.aspx?bc=BAAAAAAAAAAA&. We will no longer be providing paper copies of 

the handouts for the meeting. Electronic copies of all the meeting materials will be on 

the CMS website no later than 2 business days before the meeting. We encourage the 

participation of appropriate organizations with expertise in selected genetic tests for 

cancer diagnosis. 

II. Meeting Format 

 This meeting is open to the public. The Committee will hear oral presentations 

from the public for approximately 45 minutes. Time allotted for each presentation may 
 4 

be limited. If the number of registrants requesting to speak is greater than can be 

reasonably accommodated during the scheduled open public hearing session, we may 

conduct a lottery to determine the speakers for the scheduled open public hearing session. 

The contact person will notify interested persons regarding their request to speak by 

April 1, 2013. Your comments should focus on issues specific to the list of topics that we 

have proposed to the Committee. The list of research topics to be discussed at the 

meeting will be available on the following web site prior to the meeting: 

http://www.cms.gov/medicare-coverage-database/indexes/medcac-meetingsindex.aspx?bc=BAAAAAAAAAAA&. We require that you declare at the meeting 

whether you have any financial involvement with manufacturers (or their competitors) of 

any items or services being discussed. Speakers presenting at the MEDCAC meeting 

must include a full disclosure slide as their second slide in their presentation for financial 

interests (for example, type of financial association - consultant, research support, 

advisory board, and an indication of level, such as minor association < $10,000 or major 

association > $10,000) as well as intellectual conflicts of interest (for example, 

involvement in a federal or nonfederal advisory committee that has discussed the issue) 

that may pertain in any way to the subject of this meeting. If you are representing an 

organization, we require that you also disclose conflict of interest information for that 

organization. If you do not have a powerpoint presentation, you will need to present the 

full disclosure information requested previously at the beginning of your statement to the 

Committee. 

The Committee will deliberate openly on the topics under consideration. 

Interested persons may observe the deliberations, but the Committee will not hear further 
 5 

comments during this time except at the request of the chairperson. The Committee will 

also allow a 15-minute unscheduled open public session for any attendee to address 

issues specific to the topics under consideration. At the conclusion of the day, the 

members will vote and the Committee will make its recommendation(s) to CMS. 

III. Registration Instructions 

 CMS' Coverage and Analysis Group is coordinating meeting registration. While 

there is no registration fee, individuals must register to attend. You may register online at 

http://www.cms.gov/apps/events/upcomingevents.asp?strOrderBy=1&type=3 or by 

phone by contacting the person listed in the FOR FURTHER INFORMATION 

CONTACT section of this notice by the deadline listed in the DATES section of this 

notice. Please provide your full name (as it appears on your state-issued driver's license), 

address, organization, telephone, fax number(s), and e-mail address. You will receive a 

registration confirmation with instructions for your arrival at the CMS complex or you 

will be notified that the seating capacity has been reached. 

IV. Security, Building, and Parking Guidelines 

 This meeting will be held in a federal government building; therefore, federal 

security measures are applicable. We recommend that confirmed registrants arrive 

reasonably early, but no earlier than 45 minutes prior to the start of the meeting, to allow 

additional time to clear security. Security measures include the following: 

● Presentation of government-issued photographic identification to the Federal 

Protective Service or Guard Service personnel. 
 6 

● Inspection of vehicle's interior and exterior (this includes engine and trunk 

inspection) at the entrance to the grounds. Parking permits and instructions will be issued 

after the vehicle inspection. 

● Inspection, via metal detector or other applicable means, of all persons entering 

the building. We note that all items brought into CMS, whether personal or for the 

purpose of presentation or to support a presentation, are subject to inspection. We cannot 

assume responsibility for coordinating the receipt, transfer, transport, storage, set-up, 

safety, or timely arrival of any personal belongings or items used for presentation or to 

support a presentation. 

 Note: Individuals who are not registered in advance will not be permitted to enter 

the building and will be unable to attend the meeting. The public may not enter the 

building earlier than 45 minutes prior to the convening of the meeting. 

All visitors must be escorted in areas other than the lower and first floor levels in the 

Central Building. 
CMS-3283-N 

Authority: 5 U.S.C. App. 2, section 10(a). 

(Catalog of Federal Domestic Assistance Program No. 93.773, Medicare--Hospital 

Insurance; and Program No. 93.774, Medicare--Supplementary Medical Insurance 

Program) 

Dated: February 13, 2013

 __________________________________ 

 Patrick Conway 

 CMS Chief Medical Officer and Director, 

 Center for Clinical Standards and Quality

 Centers for Medicare & Medicaid Services.

BILLING CODE: 4120-01-P 
 8 

[FR Doc. 2013-04288 Filed 02/25/2013 at 8:45 am; Publication Date: 02/26/2013]